Biomaterial Companies

Covation Biomaterials: Emerged as an independent business after the Huafon Group acquired DuPont Biomaterials, expanding its portfolio of bio-based solutions.

Novo Nordisk: Collaborated with Aspect Biosystems to develop bioprinted tissue therapeutics for chronic diseases like obesity and diabetes, leveraging 3D printing technology for personalized medicine.

Mitsubishi Chemical: Acquired AdvanSource Biomaterials' thermoplastic polyurethane elastomer business, strengthening its global footprint in the biomaterials market.

Stryker's Qb2 InvisiFilm™: A resorbable biomaterial film for minimally invasive surgery, designed to provide temporary support and reinforcement while disappearing gradually without the need for removal.

Exparel® with Hydromorph (OXN/HCL): A new extended-release pain relief injection developed by Pacira Pharmaceuticals, offering long-lasting pain relief for orthopedic surgeries.

Biotronik's Magnis Resorbable Stent: The first fully resorbable stent approved by the FDA, designed to dissolve within two years after implantation, potentially reducing long-term complications.

• Royal DSM (Netherlands)


• BASF SE (Germany)


• Corbion N.V. (Netherlands)


• Covestro (Germany)


• Invibio Ltd. (U.K.)


• Carpenter Technology Corporation (U.S.)


• Evonik Industries AG (Germany)


• Berkeley Advanced Biomaterials Inc. (U.S.)


• CAM Bioceramics BV (Netherlands)


• Celanese Corporation (U.S.)


• Wright Medical Technology Inc. (U.S.)


• Zimmer Biomet Holdings Inc. (U.S.)


• Bayer AG (Germany)